243 related articles for article (PubMed ID: 11684825)
1. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
[TBL] [Abstract][Full Text] [Related]
2. Expression of e-cadherin and catenins in early gastric cancer.
Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ
J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224
[TBL] [Abstract][Full Text] [Related]
3. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
[TBL] [Abstract][Full Text] [Related]
4. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
5. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.
Papadavid E; Pignatelli M; Zakynthinos S; Krausz T; Chu AC
J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
7. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer.
Ramesh S; Nash J; McCulloch PG
Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738
[TBL] [Abstract][Full Text] [Related]
8. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma.
Joo YE; Rew JS; Park CS; Kim SJ
Pancreatology; 2002; 2(2):129-37. PubMed ID: 12123093
[TBL] [Abstract][Full Text] [Related]
9. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival.
Jawhari A; Jordan S; Poole S; Browne P; Pignatelli M; Farthing MJ
Gastroenterology; 1997 Jan; 112(1):46-54. PubMed ID: 8978342
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Liu J; Ikeguchi M; Nakamura S; Kaibara N
J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
[TBL] [Abstract][Full Text] [Related]
12. Expression of E-cadherin, alpha, beta and gamma-catenin in human colorectal cancer.
Hiscox S; Jiang WG
Anticancer Res; 1997; 17(2B):1349-54. PubMed ID: 9137497
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
Shimazui T; Schalken JA; Giroldi LA; Jansen CF; Akaza H; Koiso K; Debruyne FM; Bringuier PP
Cancer Res; 1996 Sep; 56(18):4154-8. PubMed ID: 8797585
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
Endo K; Ueda T; Ueyama J; Ohta T; Terada T
Hum Pathol; 2000 May; 31(5):558-65. PubMed ID: 10836294
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of E-cadherin/catenin complex expression in gastric cancer.
Joo YE; Park CS; Kim HS; Choi SK; Rew JS; Kim SJ
J Korean Med Sci; 2000 Dec; 15(6):655-66. PubMed ID: 11194192
[TBL] [Abstract][Full Text] [Related]
17. Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue.
Huang SH; Wu JC; Chang KJ; Liaw KY; Wang SM
Thyroid; 1999 Nov; 9(11):1095-103. PubMed ID: 10595458
[TBL] [Abstract][Full Text] [Related]
18. Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior.
Qian ZR; Li CC; Yamasaki H; Mizusawa N; Yoshimoto K; Yamada S; Tashiro T; Horiguchi H; Wakatsuki S; Hirokawa M; Sano T
Mod Pathol; 2002 Dec; 15(12):1357-65. PubMed ID: 12481018
[TBL] [Abstract][Full Text] [Related]
19. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM
World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911
[TBL] [Abstract][Full Text] [Related]
20. Expression of cadherins and their undercoat proteins (alpha-, beta-, and gamma-catenins and p120) and accumulation of beta-catenin with no gene mutations in synovial sarcoma.
Sato H; Hasegawa T; Kanai Y; Tsutsumi Y; Osamura Y; Abe Y; Sakai H; Hirohashi S
Virchows Arch; 2001 Jan; 438(1):23-30. PubMed ID: 11213832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]